The Role of a Second-Shell Residue in Modifying Substrate and Inhibitor Interactions in the SHV β-Lactamase: A Study of Ambler Position Asn276

被引:24
作者
Drawz, Sarah M. [4 ]
Bethel, Christopher R. [1 ]
Hujer, Kristine M. [1 ]
Hurless, Kelly N. [5 ]
Distler, Anne M. [3 ]
Caselli, Emilia [6 ]
Prati, Fabio [6 ]
Bonomo, Roberto A. [1 ,2 ,3 ]
机构
[1] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[5] St Edwards Univ, Austin, TX 78704 USA
[6] Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy
基金
美国国家卫生研究院;
关键词
CLASS-A; ESCHERICHIA-COLI; CLAVULANIC ACID; 6-METHYLIDENE PENEMS; KINETIC-ANALYSIS; ACTIVE-SITE; RESISTANT; INACTIVATION; SUBSTITUTION; INTERMEDIATE;
D O I
10.1021/bi9003292
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibitor-resistant class A beta-lactamases of the TEM and SHV families that arise by single amino acid substitutions are a significant threat to the efficacy of beta-lactam/beta-lactamase inhibitor combinations. To better understand the basis of the inhibitor-resistant phenotype in SHV, we performed mutagenesis to examine the role of a second-shell residue, Asn276. Of the 19 variants expressed in Escherichia colt, only the Asn276Asp enzyme demonstrated reduced Susceptibility to ampicillin/clavulanate (MIC increased from 50/2 -> 50/8 mu g/mL) while maintaining high-level resistance to ampicillin (MIC = 8 192 mu g/mL). steady-state kinetic analyses of Asn276Asp revealed slightly diminished k(cat)/K-m for all Substrates tested. In contrast, we observed a 5-fold increase in K-i for clavulanate (7.4 +/- 0.9 mu M for Asn276Asp vs 1.4 +/- 0.2 mu M for SHV-1) and a 40% reduction in k(inact)/K-1 (0.013 +/- 0.002 mu M-1 s(-1) for Asn276Asp vs 0.021 +/- 0.004 mu M-1 s(-1) for SHV-1). Timed electrospray ionization mass spectrometry of clavulanate-inhibited SHV-1 and SHV Asn276Asp showed nearly identical mass adducts, arguing for a similar pathway of inactivation. Molecular modeling shows that novel electrostatic interactions are formed between Arg244N eta 2 and both 276AspO delta 1 and O delta 2; these new forces restrict the spatial position of Arg244, a residue important in the recognition of the C-3/C-4 carboxylate of beta-lactam substrates and inhibitors. Testing the functional consequences of this interaction, we noted considerable free energy costs (+Delta Delta G) for substrates and inhibitors. A rigid carbapenem (meropenem) was most affected by the Asn276Asp substitution (46-fold increase in K-i vs SHV-1). We conclude that residue 276 is an important second-shell residue in class A beta-lactamase-mediated resistance to substrates and inhibitors, and only Asn is able to precisely modulate the conformational flexibility of Arg244 required for successful evolution in nature.
引用
收藏
页码:4557 / 4566
页数:10
相关论文
共 49 条
[1]   A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES [J].
AMBLER, RP ;
COULSON, AFW ;
FRERE, JM ;
GHUYSEN, JM ;
JORIS, B ;
FORSMAN, M ;
LEVESQUE, RC ;
TIRABY, G ;
WALEY, SG .
BIOCHEMICAL JOURNAL, 1991, 276 :269-270
[2]   Zinc coordination geometry and ligand binding affinity:: The structural and kinetic analysis of the second-shell serine 228 residue and the methionine 180 residue of the aminopeptidase from Vibrio proteolyticus [J].
Ataie, Niloufar J. ;
Hoang, Quyen Q. ;
Zahniser, Megan P. D. ;
Tu, Yupeng ;
Milne, Amy ;
Petsko, Gregory A. ;
Ringe, Dagmar .
BIOCHEMISTRY, 2008, 47 (29) :7673-7683
[3]   Inhibition of OXA-1 β-lactamase by penems [J].
Bethel, Christopher R. ;
Distler, Anne M. ;
Ruszczycky, Mark W. ;
Carey, Marianne P. ;
Carey, Paul R. ;
Hujer, Andrea M. ;
Taracila, Magda ;
Helfand, Marion S. ;
Thomson, Jodi M. ;
Kalp, Matthew ;
Anderson, Vernon E. ;
Leonard, David A. ;
Hujer, Kristine M. ;
Abe, Takao ;
Venkatesan, Aranapakam M. ;
Mansour, Tarek S. ;
Bonomo, Robert A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) :3135-3143
[4]   Role of Asp104 in the SHV β-lactamase [J].
Bethel, Christopher R. ;
Hujer, Andrea M. ;
Hujer, Kristine M. ;
Thomson, Jodi M. ;
Ruszczycky, Mark W. ;
Anderson, Vernon E. ;
Pusztai-Carey, Marianne ;
Taracila, Magdalena ;
Helfand, Marion S. ;
Bonomo, Robert A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) :4124-4131
[5]   Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: Observation of intermediates by electrospray ionization mass spectrometry [J].
Brown, RPA ;
Aplin, RT ;
Schofield, CJ .
BIOCHEMISTRY, 1996, 35 (38) :12421-12432
[6]  
BUSH K, 1988, Clinical Microbiology Reviews, V1, P109
[7]   KINETIC INTERACTIONS OF TAZOBACTAM WITH BETA-LACTAMASES FROM ALL MAJOR STRUCTURAL CLASSES [J].
BUSH, K ;
MACALINTAL, C ;
RASMUSSEN, BA ;
LEE, VJ ;
YANG, YJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) :851-858
[8]   Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations [J].
Buynak, JD .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) :930-940
[9]   The discovery and development of modified penicillin- and cephalosporin-derived β-lactamase inhibitors [J].
Buynak, JD .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (14) :1951-1964
[10]   Phenotypic study of resistance of β-lactamase-inhibitor-resistant TEM enzymes which differ by naturally occurring variations and by site-directed substitution at Asp276 [J].
Caniça, MM ;
Caroff, N ;
Barthélémy, M ;
Labia, R ;
Krishnamoorthy, R ;
Paul, G ;
Dupret, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1323-1328